These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24346525)

  • 1. Pseudomonas aeruginosa virulence and antimicrobial resistance: two sides of the same coin?
    Hauser AR
    Crit Care Med; 2014 Jan; 42(1):201-2. PubMed ID: 24346525
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk of developing pneumonia is enhanced by the combined traits of fluoroquinolone resistance and type III secretion virulence in respiratory isolates of Pseudomonas aeruginosa.
    Sullivan E; Bensman J; Lou M; Agnello M; Shriner K; Wong-Beringer A
    Crit Care Med; 2014 Jan; 42(1):48-56. PubMed ID: 23963124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudomonas aeruginosa OxyR is required for full virulence in rodent and insect models of infection and for resistance to human neutrophils.
    Lau GW; Britigan BE; Hassett DJ
    Infect Immun; 2005 Apr; 73(4):2550-3. PubMed ID: 15784603
    [No Abstract]   [Full Text] [Related]  

  • 4. Pseudomonas aeruginosa cell-to-cell signaling is required for virulence in a model of acute pulmonary infection.
    Pearson JP; Feldman M; Iglewski BH; Prince A
    Infect Immun; 2000 Jul; 68(7):4331-4. PubMed ID: 10858254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and pathogenesis of Pseudomonas aeruginosa infections.
    Moore NM; Flaws ML
    Clin Lab Sci; 2011; 24(1):43-6. PubMed ID: 21404964
    [No Abstract]   [Full Text] [Related]  

  • 6. Necrotizing pneumonia following cardiac surgery in a neonate.
    Al Tassan RS; Al Alola S; Al Shaalan H; Al Saleh S
    J Infect Public Health; 2013 Jun; 6(3):154-7. PubMed ID: 23668457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread.
    Allewelt M; Coleman FT; Grout M; Priebe GP; Pier GB
    Infect Immun; 2000 Jul; 68(7):3998-4004. PubMed ID: 10858214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for hospital-acquired pneumonia caused by imipenem-resistant Pseudomonas aeruginosa in an intensive care unit.
    Furtado GH; Gales AC; Perdiz LB; Santos AE; Wey SB; Medeiros EA
    Anaesth Intensive Care; 2010 Nov; 38(6):994-1001. PubMed ID: 21226427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Survival of Pseudomonas aeruginosa in the hospital environment].
    Vlodavets VV; Trukhina GM; Aĭzen MS; Moĭseenko NN; Svistunova TS
    Gig Sanit; 1986 Oct; (10):22-5. PubMed ID: 3098631
    [No Abstract]   [Full Text] [Related]  

  • 10. Fluoroquinolones in the treatment of bronchopulmonary disease in cystic fibrosis.
    Hurley M; Smyth A
    Ther Adv Respir Dis; 2012 Dec; 6(6):363-73. PubMed ID: 22968160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomonas aeruginosa revisited.
    Stratton CW
    Infect Control Hosp Epidemiol; 1990 Feb; 11(2):101-4. PubMed ID: 2107248
    [No Abstract]   [Full Text] [Related]  

  • 12.
    Zhao M; Lepak AJ; Marchillo K; Andes DR
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pseudomonas aeruginosa pneumonia].
    Watanabe K; Matsuyama N; Ikeda N
    Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):371-3. PubMed ID: 10088418
    [No Abstract]   [Full Text] [Related]  

  • 14. An outbreak of imipenem-resistant Pseudomonas aeruginosa in an intensive care unit.
    Majumdar S; Kirby A; Berry N; Williams C; Hassan I; Eddleston J; Burnie JP
    J Hosp Infect; 2004 Oct; 58(2):160-1. PubMed ID: 15474190
    [No Abstract]   [Full Text] [Related]  

  • 15. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
    Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E;
    Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An outbreak of Pseudomonas aeruginosa pneumonia and bloodstream infection associated with intermittent otitis externa in a healthcare worker.
    Zawacki A; O'Rourke E; Potter-Bynoe G; Macone A; Harbarth S; Goldmann D
    Infect Control Hosp Epidemiol; 2004 Dec; 25(12):1083-9. PubMed ID: 15636297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An adenylate cyclase-controlled signaling network regulates Pseudomonas aeruginosa virulence in a mouse model of acute pneumonia.
    Smith RS; Wolfgang MC; Lory S
    Infect Immun; 2004 Mar; 72(3):1677-84. PubMed ID: 14977975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between rates of antimicrobial consumption and the incidence of antimicrobial resistance in Staphylococcus aureus and Pseudomonas aeruginosa isolates from 47 French hospitals.
    Rogues AM; Dumartin C; Amadéo B; Venier AG; Marty N; Parneix P; Gachie JP
    Infect Control Hosp Epidemiol; 2007 Dec; 28(12):1389-95. PubMed ID: 17994520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diversity of virulence genes in multidrug resistant Pseudomonas aeruginosa isolated from burn wound infections.
    Haghi F; Zeighami H; Monazami A; Toutouchi F; Nazaralian S; Naderi G
    Microb Pathog; 2018 Feb; 115():251-256. PubMed ID: 29273509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The genus Pseudomonas: new aspects of an old problem].
    Kalina GP
    Zh Mikrobiol Epidemiol Immunobiol; 1985 May; (5):91-8. PubMed ID: 3929504
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.